Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Sona Nanotech Inc
Bullboard Posts
User Avatar Image
(206)
•••
Comment by Hightide22on Jul 08, 2020 3:47pm
116 Views
Post# 31241399

RE:RE:RE:RE:RE:RE:RE:Just Heard this

RE:RE:RE:RE:RE:RE:RE:Just Heard this
so you want us to make you feel great by telling you your call of selling at $9.00 and re buying again was a great call.
are you that insecure, or do you think we don’t know how to play the swings.

get lost cockroach 


Moemoney42 - (7/8/2020 3:25:30 PM)
RE:RE:RE:RE:RE:RE:Just Heard this
PatrickBateman wrote:I have a job and a damn good one at that. Sucks that my tax dollars are going to fund low life scum like you, Moe.

Ahhh what's the matter Pat... sounds like you're p!ssed... funny how when someone can come on these boards make a great suggestion that could have been played to make some nice profits with a sell and buy within a few days, and get hammered by moronic posters here with such big egos they can't admit it was a good call and say... hey man thanks for the heads up and trading lesson... made some quick bucks and I'm still in the game..! Then you have people like you calling names because you missed the opportunity for funny money... I guess when you're insecure that's your outlet... sad..!

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested